PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2320.0
(-1.28%)
IDR 2320.0
(-1.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 28507.87 Billion IDR | 1.71% |
| 2022 | 28027.48 Billion IDR | 9.17% |
| 2021 | 25673.75 Billion IDR | 13.88% |
| 2020 | 22545.41 Billion IDR | 1.43% |
| 2019 | 22226.91 Billion IDR | 7.87% |
| 2018 | 20604.48 Billion IDR | 4.76% |
| 2017 | 19669.09 Billion IDR | 3.87% |
| 2016 | 18936.24 Billion IDR | 8.36% |
| 2015 | 17476.1 Billion IDR | 2.73% |
| 2014 | 17011.54 Billion IDR | 8.89% |
| 2013 | 15623.23 Billion IDR | 16.83% |
| 2012 | 13373.03 Billion IDR | 26.04% |
| 2011 | 10610.08 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 7580.85 Billion IDR | -0.68% |
| 2024 Q1 | 7976.51 Billion IDR | 8.16% |
| 2024 Q2 | 7632.77 Billion IDR | -4.31% |
| 2023 Q3 | 7059.54 Billion IDR | 3.3% |
| 2023 FY | 28507.87 Billion IDR | 1.71% |
| 2023 Q1 | 7239.57 Billion IDR | 0.61% |
| 2023 Q2 | 6833.7 Billion IDR | -5.61% |
| 2023 Q4 | 7375.04 Billion IDR | 4.47% |
| 2022 Q1 | 6798.8 Billion IDR | -0.85% |
| 2022 FY | 28027.48 Billion IDR | 9.17% |
| 2022 Q4 | 7195.68 Billion IDR | 1.24% |
| 2022 Q3 | 7107.31 Billion IDR | 2.62% |
| 2022 Q2 | 6925.68 Billion IDR | 1.87% |
| 2021 Q3 | 6585.38 Billion IDR | 2.01% |
| 2021 Q2 | 6455.56 Billion IDR | 11.77% |
| 2021 Q4 | 6857.1 Billion IDR | 4.13% |
| 2021 Q1 | 5775.7 Billion IDR | 1.75% |
| 2021 FY | 25673.75 Billion IDR | 13.88% |
| 2020 Q1 | 5574.18 Billion IDR | -2.99% |
| 2020 FY | 22545.41 Billion IDR | 1.43% |
| 2020 Q2 | 5927.58 Billion IDR | 6.34% |
| 2020 Q3 | 5367.07 Billion IDR | -9.46% |
| 2020 Q4 | 5676.56 Billion IDR | 5.77% |
| 2019 FY | 22226.91 Billion IDR | 7.87% |
| 2019 Q3 | 5475.3 Billion IDR | -7.15% |
| 2019 Q4 | 5746.13 Billion IDR | 4.95% |
| 2019 Q1 | 5108.51 Billion IDR | -6.72% |
| 2019 Q2 | 5896.95 Billion IDR | 15.43% |
| 2018 Q2 | 5358.14 Billion IDR | 13.18% |
| 2018 Q1 | 4734.35 Billion IDR | -7.25% |
| 2018 Q4 | 5476.39 Billion IDR | 8.75% |
| 2018 FY | 20604.48 Billion IDR | 4.76% |
| 2018 Q3 | 5035.58 Billion IDR | -6.02% |
| 2017 Q2 | 5172 Billion IDR | 11.65% |
| 2017 FY | 19669.09 Billion IDR | 3.87% |
| 2017 Q4 | 5104.51 Billion IDR | 7.23% |
| 2017 Q3 | 4760.15 Billion IDR | -7.96% |
| 2017 Q1 | 4632.42 Billion IDR | -7.28% |
| 2016 Q4 | 4996.08 Billion IDR | 10.01% |
| 2016 FY | 18936.24 Billion IDR | 8.36% |
| 2016 Q3 | 4541.44 Billion IDR | -8.97% |
| 2016 Q2 | 4989.1 Billion IDR | 13.14% |
| 2016 Q1 | 4409.6 Billion IDR | -8.24% |
| 2015 FY | 17476.1 Billion IDR | 2.73% |
| 2015 Q4 | 4805.77 Billion IDR | 12.93% |
| 2015 Q3 | 4255.61 Billion IDR | -1.93% |
| 2015 Q2 | 4339.58 Billion IDR | 6.49% |
| 2015 Q1 | 4075.12 Billion IDR | -10.07% |
| 2014 FY | 17011.54 Billion IDR | 8.89% |
| 2014 Q4 | 4531.6 Billion IDR | 6.31% |
| 2014 Q3 | 4262.76 Billion IDR | 0.67% |
| 2014 Q2 | 4234.37 Billion IDR | 6.32% |
| 2014 Q1 | 3982.8 Billion IDR | -10.83% |
| 2013 Q4 | 4466.64 Billion IDR | 15.2% |
| 2013 FY | 15623.23 Billion IDR | 16.83% |
| 2013 Q1 | 3433.44 Billion IDR | -9.28% |
| 2013 Q2 | 3845.94 Billion IDR | 12.01% |
| 2013 Q3 | 3877.2 Billion IDR | 0.81% |
| 2012 Q1 | 2956.4 Billion IDR | 0.0% |
| 2012 FY | 13373.03 Billion IDR | 26.04% |
| 2012 Q3 | 3378.13 Billion IDR | 3.82% |
| 2012 Q4 | 3784.73 Billion IDR | 12.04% |
| 2012 Q2 | 3253.75 Billion IDR | 10.06% |
| 2011 FY | 10610.08 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 696.3 Billion IDR | -3994.172% |
| PT Kimia Farma (Persero) Tbk | 9965.03 Billion IDR | -186.079% |
| PT Millennium Pharmacon International Tbk | 3363.51 Billion IDR | -747.561% |
| PT Soho Global Health Tbk | 8197.75 Billion IDR | -247.752% |